1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Animal-Free Recombinant Proteins Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Animal-Free Recombinant Proteins by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Animal-Free Recombinant Proteins by Country/Region, 2018, 2022 & 2029
2.2 Animal-Free Recombinant Proteins Segment by Type
2.2.1 Preclinical Proteins
2.2.2 GMP Proteins
2.3 Animal-Free Recombinant Proteins Sales by Type
2.3.1 Global Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
2.3.2 Global Animal-Free Recombinant Proteins Revenue and Market Share by Type (2018-2023)
2.3.3 Global Animal-Free Recombinant Proteins Sale Price by Type (2018-2023)
2.4 Animal-Free Recombinant Proteins Segment by Application
2.4.1 Cell Therapy Manufacturing
2.4.2 Other
2.5 Animal-Free Recombinant Proteins Sales by Application
2.5.1 Global Animal-Free Recombinant Proteins Sale Market Share by Application (2018-2023)
2.5.2 Global Animal-Free Recombinant Proteins Revenue and Market Share by Application (2018-2023)
2.5.3 Global Animal-Free Recombinant Proteins Sale Price by Application (2018-2023)
3 Global Animal-Free Recombinant Proteins by Company
3.1 Global Animal-Free Recombinant Proteins Breakdown Data by Company
3.1.1 Global Animal-Free Recombinant Proteins Annual Sales by Company (2018-2023)
3.1.2 Global Animal-Free Recombinant Proteins Sales Market Share by Company (2018-2023)
3.2 Global Animal-Free Recombinant Proteins Annual Revenue by Company (2018-2023)
3.2.1 Global Animal-Free Recombinant Proteins Revenue by Company (2018-2023)
3.2.2 Global Animal-Free Recombinant Proteins Revenue Market Share by Company (2018-2023)
3.3 Global Animal-Free Recombinant Proteins Sale Price by Company
3.4 Key Manufacturers Animal-Free Recombinant Proteins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal-Free Recombinant Proteins Product Location Distribution
3.4.2 Players Animal-Free Recombinant Proteins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Animal-Free Recombinant Proteins by Geographic Region
4.1 World Historic Animal-Free Recombinant Proteins Market Size by Geographic Region (2018-2023)
4.1.1 Global Animal-Free Recombinant Proteins Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Animal-Free Recombinant Proteins Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Animal-Free Recombinant Proteins Market Size by Country/Region (2018-2023)
4.2.1 Global Animal-Free Recombinant Proteins Annual Sales by Country/Region (2018-2023)
4.2.2 Global Animal-Free Recombinant Proteins Annual Revenue by Country/Region (2018-2023)
4.3 Americas Animal-Free Recombinant Proteins Sales Growth
4.4 APAC Animal-Free Recombinant Proteins Sales Growth
4.5 Europe Animal-Free Recombinant Proteins Sales Growth
4.6 Middle East & Africa Animal-Free Recombinant Proteins Sales Growth
5 Americas
5.1 Americas Animal-Free Recombinant Proteins Sales by Country
5.1.1 Americas Animal-Free Recombinant Proteins Sales by Country (2018-2023)
5.1.2 Americas Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
5.2 Americas Animal-Free Recombinant Proteins Sales by Type
5.3 Americas Animal-Free Recombinant Proteins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal-Free Recombinant Proteins Sales by Region
6.1.1 APAC Animal-Free Recombinant Proteins Sales by Region (2018-2023)
6.1.2 APAC Animal-Free Recombinant Proteins Revenue by Region (2018-2023)
6.2 APAC Animal-Free Recombinant Proteins Sales by Type
6.3 APAC Animal-Free Recombinant Proteins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Animal-Free Recombinant Proteins by Country
7.1.1 Europe Animal-Free Recombinant Proteins Sales by Country (2018-2023)
7.1.2 Europe Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
7.2 Europe Animal-Free Recombinant Proteins Sales by Type
7.3 Europe Animal-Free Recombinant Proteins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Animal-Free Recombinant Proteins by Country
8.1.1 Middle East & Africa Animal-Free Recombinant Proteins Sales by Country (2018-2023)
8.1.2 Middle East & Africa Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
8.2 Middle East & Africa Animal-Free Recombinant Proteins Sales by Type
8.3 Middle East & Africa Animal-Free Recombinant Proteins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal-Free Recombinant Proteins
10.3 Manufacturing Process Analysis of Animal-Free Recombinant Proteins
10.4 Industry Chain Structure of Animal-Free Recombinant Proteins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal-Free Recombinant Proteins Distributors
11.3 Animal-Free Recombinant Proteins Customer
12 World Forecast Review for Animal-Free Recombinant Proteins by Geographic Region
12.1 Global Animal-Free Recombinant Proteins Market Size Forecast by Region
12.1.1 Global Animal-Free Recombinant Proteins Forecast by Region (2024-2029)
12.1.2 Global Animal-Free Recombinant Proteins Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Animal-Free Recombinant Proteins Forecast by Type
12.7 Global Animal-Free Recombinant Proteins Forecast by Application
13 Key Players Analysis
13.1 BioVision
13.1.1 BioVision Company Information
13.1.2 BioVision Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.1.3 BioVision Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioVision Main Business Overview
13.1.5 BioVision Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.2.3 Bio-Techne Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Abcam
13.3.1 Abcam Company Information
13.3.2 Abcam Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.3.3 Abcam Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abcam Main Business Overview
13.3.5 Abcam Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.4.3 Merck Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. Animal-Free Recombinant Proteins Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Animal-Free Recombinant Proteins Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preclinical Proteins
Table 4. Major Players of GMP Proteins
Table 5. Global Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 6. Global Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Table 7. Global Animal-Free Recombinant Proteins Revenue by Type (2018-2023) & ($ million)
Table 8. Global Animal-Free Recombinant Proteins Revenue Market Share by Type (2018-2023)
Table 9. Global Animal-Free Recombinant Proteins Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 11. Global Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Table 12. Global Animal-Free Recombinant Proteins Revenue by Application (2018-2023)
Table 13. Global Animal-Free Recombinant Proteins Revenue Market Share by Application (2018-2023)
Table 14. Global Animal-Free Recombinant Proteins Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Animal-Free Recombinant Proteins Sales by Company (2018-2023) & (K Units)
Table 16. Global Animal-Free Recombinant Proteins Sales Market Share by Company (2018-2023)
Table 17. Global Animal-Free Recombinant Proteins Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Animal-Free Recombinant Proteins Revenue Market Share by Company (2018-2023)
Table 19. Global Animal-Free Recombinant Proteins Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Animal-Free Recombinant Proteins Producing Area Distribution and Sales Area
Table 21. Players Animal-Free Recombinant Proteins Products Offered
Table 22. Animal-Free Recombinant Proteins Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Animal-Free Recombinant Proteins Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Animal-Free Recombinant Proteins Sales Market Share Geographic Region (2018-2023)
Table 27. Global Animal-Free Recombinant Proteins Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Animal-Free Recombinant Proteins Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Animal-Free Recombinant Proteins Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Animal-Free Recombinant Proteins Sales Market Share by Country/Region (2018-2023)
Table 31. Global Animal-Free Recombinant Proteins Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Animal-Free Recombinant Proteins Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 34. Americas Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 35. Americas Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 37. Americas Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 38. Americas Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 39. APAC Animal-Free Recombinant Proteins Sales by Region (2018-2023) & (K Units)
Table 40. APAC Animal-Free Recombinant Proteins Sales Market Share by Region (2018-2023)
Table 41. APAC Animal-Free Recombinant Proteins Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Animal-Free Recombinant Proteins Revenue Market Share by Region (2018-2023)
Table 43. APAC Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 44. APAC Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 45. Europe Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 46. Europe Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 47. Europe Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 49. Europe Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 50. Europe Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Animal-Free Recombinant Proteins
Table 58. Key Market Challenges & Risks of Animal-Free Recombinant Proteins
Table 59. Key Industry Trends of Animal-Free Recombinant Proteins
Table 60. Animal-Free Recombinant Proteins Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Animal-Free Recombinant Proteins Distributors List
Table 63. Animal-Free Recombinant Proteins Customer List
Table 64. Global Animal-Free Recombinant Proteins Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Animal-Free Recombinant Proteins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Animal-Free Recombinant Proteins Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Animal-Free Recombinant Proteins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Animal-Free Recombinant Proteins Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Animal-Free Recombinant Proteins Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Animal-Free Recombinant Proteins Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Animal-Free Recombinant Proteins Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. BioVision Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 79. BioVision Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 80. BioVision Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. BioVision Main Business
Table 82. BioVision Latest Developments
Table 83. Bio-Techne Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Techne Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 85. Bio-Techne Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bio-Techne Main Business
Table 87. Bio-Techne Latest Developments
Table 88. Abcam Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 89. Abcam Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 90. Abcam Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abcam Main Business
Table 92. Abcam Latest Developments
Table 93. Merck Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 95. Merck Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
List of Figures
Figure 1. Picture of Animal-Free Recombinant Proteins
Figure 2. Animal-Free Recombinant Proteins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal-Free Recombinant Proteins Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Animal-Free Recombinant Proteins Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Animal-Free Recombinant Proteins Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preclinical Proteins
Figure 10. Product Picture of GMP Proteins
Figure 11. Global Animal-Free Recombinant Proteins Sales Market Share by Type in 2022
Figure 12. Global Animal-Free Recombinant Proteins Revenue Market Share by Type (2018-2023)
Figure 13. Animal-Free Recombinant Proteins Consumed in Cell Therapy Manufacturing
Figure 14. Global Animal-Free Recombinant Proteins Market: Cell Therapy Manufacturing (2018-2023) & (K Units)
Figure 15. Animal-Free Recombinant Proteins Consumed in Other
Figure 16. Global Animal-Free Recombinant Proteins Market: Other (2018-2023) & (K Units)
Figure 17. Global Animal-Free Recombinant Proteins Sales Market Share by Application (2022)
Figure 18. Global Animal-Free Recombinant Proteins Revenue Market Share by Application in 2022
Figure 19. Animal-Free Recombinant Proteins Sales Market by Company in 2022 (K Units)
Figure 20. Global Animal-Free Recombinant Proteins Sales Market Share by Company in 2022
Figure 21. Animal-Free Recombinant Proteins Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Animal-Free Recombinant Proteins Revenue Market Share by Company in 2022
Figure 23. Global Animal-Free Recombinant Proteins Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Animal-Free Recombinant Proteins Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 26. Americas Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 27. APAC Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 28. APAC Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 29. Europe Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 30. Europe Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 33. Americas Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 34. Americas Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 35. Americas Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 36. Americas Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 37. United States Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Animal-Free Recombinant Proteins Sales Market Share by Region in 2022
Figure 42. APAC Animal-Free Recombinant Proteins Revenue Market Share by Regions in 2022
Figure 43. APAC Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 44. APAC Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 45. China Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 53. Europe Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 54. Europe Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 55. Europe Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 56. Germany Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 65. Egypt Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Animal-Free Recombinant Proteins in 2022
Figure 71. Manufacturing Process Analysis of Animal-Free Recombinant Proteins
Figure 72. Industry Chain Structure of Animal-Free Recombinant Proteins
Figure 73. Channels of Distribution
Figure 74. Global Animal-Free Recombinant Proteins Sales Market Forecast by Region (2024-2029)
Figure 75. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Animal-Free Recombinant Proteins Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Animal-Free Recombinant Proteins Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Application (2024-2029)
| ※参考情報 非動物性組換えタンパク質（Animal-Free Recombinant Proteins）は、動物由来の成分を一切含まない組換えDNA技術を用いて生産されるタンパク質です。このコンセプトは、バイオテクノロジーの進歩により、食品、医薬品、化粧品、研究材料などの分野で急速に拡がっています。 まず、非動物性組換えタンパク質の定義について見ていきましょう。伝統的に、組換えタンパク質は細胞や微生物を利用して生成されるものであり、その多くは動物の細胞や組織を用いた培地で育てられることが一般的でした。しかし、非動物性組換えタンパク質は、動物から一切の成分を排除した培養システムを利用しています。これにより、動物福利の問題を回避し、また、アレルゲンや病原体のリスクを減少させることができます。 次に、特徴について見てみましょう。非動物性組換えタンパク質は、その生産過程で動物由来の成分を避けるため、従来の製品に比べて純度が高いという特長があります。また、動物由来成分の不使用は、アレルギーのリスクを軽減することにも寄与します。さらに、持続可能な生産方法であることも大きな特徴です。これにより、環境への負担を軽減し、持続可能な食品供給体制の一翼を担うことが期待されます。 次に、非動物性組換えタンパク質の種類について考えます。このタンパク質は、例えば、酵母、バクテリア、藻類及び植物細胞など、さまざまな微生物や植物から生産されます。例えば、酵母は大量生産が可能であり、成長速度が速いという利点があります。バクテリアも同様に、短い時間で増殖し、コスト効率の良い生産が可能です。藻類や植物細胞は、特定の栄養素を豊富に含むため、さらに多様な機能を持つタンパク質の生産が期待されています。 用途に関しては、非動物性組換えタンパク質はさまざまな分野で利用されています。食品業界では、植物由来のタンパク質を使用した代替肉やタンパク質強化食品としての需要が高まっています。これにより、動物性タンパク質の消費を抑え、健康的かつ環境に優しい食品としての選択肢を提供します。医薬品の分野では、非動物性組換えタンパク質を基にしたワクチンや酵素治療薬などが開発されています。これにより、安心して使用できる医薬品を提供することができ、特に動物由来の成分に対するアレルギーを持つ患者にとっては大きな利点となります。化粧品の分野でも、非動物性の成分が求められており、動物実験に対する倫理的懸念が高まる中で、こうした製品が支持を受けています。 関連技術についても触れておくべきでしょう。非動物性組換えタンパク質の生産においては、合成生物学や遺伝子工学の技術が重要な役割を果たしています。これらの技術により、特定の機能を持つタンパク質をデザインし、効率的に生産することが可能になります。また、発酵技術や培養技術の進歩も大きな貢献をしています。これにより、コスト削減や生産効率の向上が図られています。 さらに、非動物性組換えタンパク質の評価や規制に関しても考慮が必要です。食品や医薬品としての安全性や有効性を評価するための基準が設けられており、これに従った研究や試験が求められています。このような評価基準の策定は、消費者の信頼を獲得するためにも重要であり、産業全体の発展につながります。 そして、非動物性組換えタンパク質の未来についても考えてみましょう。持続可能な食糧供給がますます求められる中で、非動物性のタンパク質生産はますます重要な役割を果たしていくでしょう。消費者のニーズが高まる中で、より多様な製品が市場に登場し、選択肢も増えると予測されます。さらに、技術の進展が進めば、非動物性組換えタンパク質の生産コストが低下し、普及が進むことも期待されます。 総じて、非動物性組換えタンパク質は、現代の食文化や医療のニーズに応える重要な解決策であると言えるでしょう。その成長は、倫理観や環境意識の高まりとも相まって、今後も加速していくと考えられます。私たちの社会が直面する課題に立ち向かうための一助となることが期待されるこの分野は、今後ますます注目を集めることでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
